The price target for CME Group (NASDAQ: CME) was reduced by stock analysts at UBS Group, who brought it down from $226.00 to $220.00. The Fly published the report. Thursday was the day that the research note was made public. According to the price objective that UBS Group provided, the share price could rise by 29.35% compared to its most recent closing price.
Recently, the company has had comments from a plethora of additional stock research specialists who have provided their input. Citigroup released its first research report on CME Group on October 11, which was also the day that the report was published. They suggested purchasing the stock for $220.00 and establishing a goal of reaching that level. Deutsche Bank Aktiengesellschaft announced, in a research note made public on Thursday, October 27, that they were increasing their price target on CME Group from $200.00 to $202.00. The target price of CME Group, which Morgan Stanley established in a research report published on October 27, dropped from $213.00 to $208.00, and the company rated the stock as “equal weight.” CME Group shares were given a “sell” rating by Rosenblatt Securities in a research report published on Wednesday, October 5. In addition, the brokerage firm decreased its price objective for the stock from $171.00 to $161.00. StockNews.com announced the publication of its first research study on CME Group on October 12. This was something that the company had been planning to do for some time. They advised their clients to “hold” the stock moving forward. Eight of the research experts have provided the company with a recommendation to buy its stock, six of the research experts have provided a recommendation to hold their shares, and two of the research experts have provided a recommendation to sell their shares. The data provided by Bloomberg indicates that the current average rating for the company is “Hold” and that the company’s price target has been set at $223.00.
Trading on the NASDAQ: CME began on Thursday for $170.08 per share. The company has a market capitalization of $61.18 billion, a price-to-earnings ratio of 23.14, a price-to-earnings-to-growth ratio of 2.60, and a beta of 0.40. The ratio of price to earnings to growth is 2.60, and the ratio of price to earnings to growth is also 23.14. The moving average price of the stock over the previous 50 days is $173.58, and the moving average price over the previous 200 days is $186.81. The price of CME Group has fluctuated between $166.54 and $256.94 over the previous 52 weeks. The company’s debt-to-equity ratio comes in at 0.12, its quick ratio is 1.02, and its current ratio also comes in at 1.02.
CME Group (NASDAQ: CME) announced the publication of its financial results for the third quarter on Wednesday, October 26. The financial services company reported earnings per share (EPS) of $1.98 for the quarter, which was $0.05 higher than the average forecast of $1.93 and broke the previous record of $1.93. The revenue for the company was $1.23 billion for the quarter, which is in line with the average projection of $1.23 billion for the company’s revenue. CME Group had a return on equity of 10.06%, and its net margin was 54.01% for the company. According to analysts who specialize in equity analysis, the CME Group is expected to generate 7.98 cents in profits per share this year.
In related news, on November 4, the most recent trading day, Company Director William R. Shepard purchased 48,645 shares of company stock. This was the most recent news regarding this transaction. The total value of the acquired stock was $8,269,650.00, which corresponds to an average price of $170 per share when it was bought. Following the successful completion of the acquisition, the director now owns 247,843 shares of the company’s stock. These shares have an approximate value of $42,133,310. On the Securities and Exchange Commission’s (SEC) website, you can access the information submitted to the SEC regarding the transaction, which is currently available. Insiders of the company currently hold 0.30% of the total number of shares outstanding.
Over the last few months, institutional investors have bought and sold company shares in various transactions. During the first three months of 2019, the value of Capital International Investors’ holdings in CME Group increased by 8.4%. Following the completion of additional transactions throughout the period, Capital International Investors now owns a total of 14,292,196 shares of stock in the business that specializes in financial services. The value of these shares on the market as of right now is $3,400,650,000 in total. At the end of the second quarter, Renaissance Technologies LLC owned a total of 1.1 million shares of CME Group, which was 208.9% more than it had at the beginning of the quarter. Renaissance Technologies LLC now owns the stock held by the financial services provider to 854,289 shares after the company made an additional purchase of 577,700 shares during the most recent quarter. The value of these shares as of right now is $174,873,000 in total. CCLA Investment Management expanded its holdings in CME Group during the third quarter by purchasing additional company shares. The price of these brand-new shares came to a total of $87,735,000. During the first three months of this year, Vanguard Group Inc. increased the percentage of CME Group stock owned by 1.6%. Vanguard Group Inc. now owns a total of 31,847,850 shares of the stock held by the financial services provider after purchasing an additional 490,885 shares during the most recent month to bring the total number of shares owned by the company to a total. The value of these shares as of right now is $7,575,330,000 in total. Not to be outdone, the Massachusetts Financial Services Company, MA, during the second quarter, increased the proportion of CME Group stock that is owned by 10.3%. The Massachusetts Financial Services Co., MA, now has a total of 3,732,293 shares of the financial services provider’s stock, which have a value of $764,000,000, following the purchase of an additional 349,520 shares during the period in question. These shares bring the company’s total share count to 3,732,293. Institutional investors hold a stake in the company equal to 85.09% of the total equity of the company.
CME Group Inc. and its subsidiaries manage the contract markets on which futures and options on futures contracts are exchanged. These exchanges can be found in many different countries around the world. In addition to fixed-income products, it offers options and futures on equity, foreign exchange, agricultural commodities, energy, and metals; it also monitors interest rates and provides an equity index.